Form 13-F position report

YIELD10 BIOSCIENCE INC COM

Reported by Birchview Capital LP

YTEN CUSIP 98585K102 Manager CIK 0001618205

Reported 0 shares, down 18,750 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 30 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 92000
2022-03-31 99000
2022-06-30 42000
2022-09-30 56000
2022-12-31 31000
2023-03-31 52000
2023-06-30 41625
2023-09-30 6126
2023-12-31 4487
2024-03-31 7125
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for YIELD10 BIOSCIENCE INC COM held by Birchview Capital LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -18,750 (-100.0%) 0 $0 2024-08-13
Q1 2024 Unchanged 18,750 0 (0.0%) < 0.01% $7,125 2024-05-14
Q4 2023 Unchanged 18,750 0 (0.0%) < 0.01% $4,487 2024-02-14
Q3 2023 Unchanged 18,750 0 (0.0%) < 0.01% $6,126 2023-11-14
Q2 2023 Unchanged 18,750 0 (0.0%) 0.03% $41,625 2023-08-08
Q1 2023 Unchanged 18,750 0 (0.0%) 0.04% $52,000 2023-05-12
Q4 2022 Unchanged 18,750 0 (0.0%) 0.02% $31,000 2023-02-03
Q3 2022 Unchanged 18,750 0 (0.0%) 0.04% $56,000 2022-11-07
Q2 2022 Unchanged 18,750 0 (0.0%) 0.03% $42,000 2022-08-12
Q1 2022 Unchanged 18,750 0 (0.0%) 0.07% $99,000 2022-05-13
Q4 2021 Reduced 18,750 -35 (-0.2%) 0.06% $92,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1 manager reported YIELD10 BIOSCIENCE INC COM for Q2 2024.

Managers reporting YIELD10 BIOSCIENCE INC COM in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Birchview Capital LP This report Reduced 0 -18,750 0 $0 30 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 13, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.